Nicholas G. Demetriades
President and Co-Founder of Alsteni Medical, Inc. Named inventor on U.S. Patent 12,599,544 (issued April 14, 2026). Leads commercial strategy, partnerships, regulatory operations, and capital formation for the development of the first new enteral access route since PEG was invented in 1979. USC Techstars 2025 inaugural cohort. Former U.S. Marine.
Washington State University alumnus (BS, Strategic Communication, Edward R. Murrow College of Communication). Master's degree from Neapolis University Pafos. Completed the Accelerated Marketing Leadership Program at Northwestern University Kellogg School of Management Executive Education.
Former U.S. Marine — 0311 Infantry, Reserves (2014–2018). Prior to Alsteni, built and ran the digital marketing engine that generated $30M+ in international property sales for Leptos Group — Cyprus's largest private property developer — on track for Marketing Director before leaving to commercialize the Alsteni System.
Named inventor on U.S. Patent 12,599,544, "Intraoral Gastrointestinal Access Device and Related Methods," issued April 14, 2026. Co-inventors: Elizabeth O. Beale, MD (CEO, inventor of record) and Todd Oda (CTO). Part of a portfolio that includes U.S. Patent 10,744,070 (issued, through 2039), a PCT international filing (WO2025235457), and multiple pending continuations.
Operates as the sole operational founder, directing AI as a full-stack execution layer across fundraising, investor relations, regulatory strategy, competitive intelligence, and go-to-market — replacing the output of 5–10 early hires. Manages a 2,000+ contact CRM, cold outreach infrastructure, financial models, clinical site coordination, and the company's full commercial operating system. Currently leading Alsteni's $4M seed round.